Health

CEO of China's Sinovac: Covid vaccine ready for mass use by early 2021

Beijing, Sep 24 (EFE), (Camera: Javier García).- A Covid-19 vaccine currently in the advanced stages of testing will be ready for mass public use by early next year, the president of Chinese pharmaceutical firm Sinovac Biotech said Thursday.Yin Weidong told Efe and other media on a tour of Sinovac’s laboratories and factory in Beijing that the company had the capacity to produce 300 million doses of the vaccine, called CoronaVac, each year.Sinovac began constructing a specialized research laboratory for Covid-19 immunization in March and has been producing the potential future vaccine for several weeks.Yin said researchers explored seven different methods of vaccination and found that the use of the “inactivated vaccine” had proven to be the most effective.He said that phase III testing in subjects over 18-years-old had not shown any side-effects and that the vaccine was capable of immunizing all the variations of SARS-Cov-2 in the world.FOOTAGE OF SINOVAC BIOTECH.SOUNDBITES OF YIN WEIDONG, PRESIDENT OF SINOVAC:"We estimate that the vaccine can be applied to the general population early next year."